DanielAllanHamstraMDPhD(He/Him)

PubMed

• Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
  Sagar A Patel, Dattatraya Patil, Joseph Smith, Christopher S Saigal, Mark S Litwin
  JAMA Network Open. 2024-10-01
• 5 citations
  Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
  Sujith Baliga, Samir Patel, Issam El Naqa, X Allen Li, Laurie E Cohen
  International Journal of Radiation Oncology, Biology, Physics. 2024-06-01
• Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
  Elizabeth E Dong, Junqian Xu, Joo-Won Kim, Jason Bryan, Jewel Appleton
  Radiation Oncology. 2024-03-13

Journal Articles

• Interval to Biochemical Failure Predicts Clinical Outcomes in Patients with High-Risk Prostate Cancer Treated by Combined-Modality Radiotherapy  
  Shilkrut, M., McLaughlin, P.W., Merrick, G.S., Vainshtein, J.M., Feng, FY., and Hamstra, D.A., Int J Rad Bio Oncol Phys, 5/9/2013
• The Interval to Biochemical Failure is Prognostic for Metastasis, Prostate Cancer Specific and Overall Mortality Following Salvage Radiotherapy for Prostate Cancer  
  Johnson, S.B., Jackson, W.C., Foster, C., Li., D., Palapattu, G.S., Sandler, H.M., Feng, F.Y., and Hamstra, D.A., Int J Rad Bio Oncol Phys, 4/2/2013
• Multi-Institutional Prospective Evaluation of Bowel Quality of Life After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors Associated ...  
  Hamstra, D.A., Conlon, A.S.C., Daignault, S., Dunn, R.L, Sandler, H.M., Hembroff, A.L,, Zietman, A.L., Kaplan, I., Ciezki, J., Kuban, D., Wei, J.T., Sanda, M.G., and M..., Int J Rad Bio Oncol Phys, 4/2/2013
• The Dosimetric Impact of Prostate Rotation During Electromagnetically Guided External Beam Radiation Therapy  
  Amro, H., Hamstra, D.A, McShan, D., Sandler, H., Vineberg, K, Hadley, S., and Litzenberg, D, Int J Radiat Oncol Biol Phys, 1/1/2013
• Retrospective Evaluation Reveals that Long-Term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation fo...  
  Feng, F.Y., Blas, K., Olson, K.B., Stenmark, M., Sandler, H.M., and Hamstra, D.A., Int J Rad Bio Oncol Phys, 1/1/2013
• The Addition of Low Dose Rate Brachytherapy and Androgen Deprivation Therapy Decreases Biochemical Failure and Prostate Cancer Death Compared to Dose Escalated Externa...  
  Shilkrut, M., Merrick, G.S., McLaughlin, P.W., Stenmark, M.H., Abu-Isa, E., Vance, S.M., Sandler, H.M., Feng, F.Y., and Hamstra, D.A., Cancer, 1/1/2013
• Patient Reported Outcomes Following 3D Conformal, Intensity-Modulated, or Proton Beam Radiotherapy For Localized Prostate Cancer  
  Gray, P.J., Paly, J.J., Yeap, B.Y., Sanda, M.G., Sandler, H.M., Michalski, J.M., Talcott, J.A., Coen, J.J., Hamstra, D.A., Shipley, W.U., Hahn, S.M., Zietman, A.L., Be..., Cancer, 1/1/2013
• Uncertainty and Danger Among Survivors of Prostate Cancer  
  Kazer, M.W., Bailey D.E. Jr., Chipman, J., Psutka, S., Hardy, J., Hembroff, L., Regan, M., Dunn, R., Crocian, C., Sanda, M., and the PROSTQA Consortium, BJU International, 1/1/2013
• Spouses' long-term appraisal of their caregiving experience, marital satisfaction, sexual satisfaction and quality of life 2 years after prostate cancer treatment  
  Harden, J., Sanda, M.G., Wei, J.T., Yarandi, H., Hembroff, L., Hardy, J., Northouse, L., and the PROST-QA Study Group, Cancer Nurs, 6/1/2012
• Predicting Treatment Efficacy via Quantitative Magnetic Resonance Imaging: a Bayesian Joint Model  
  Wu, J., Johnson, T.D., Galban, C.J., Chenevert, T.L., Meyer, C.R., Rehemtulla, A., Hamstra, D.A., and Ross, B.D., Appl Statist, 1/1/2012
• The interval to biochemical failure as a biomarker for cause specific and overall survival following dose-escalated external beam radiation therapy for prostate cancer  
  Kapadia, N., Olson, K, Sandler, H.M., Feng, F.Y., and Hamstra, D.A., Cancer, 1/1/2012
• General commentary to the “Management of biochemical recurrence after primary localized therapy for prostate cancer” [Letter to Editor]  
  Shilkrut, M., Feng, F.Y., and Hamstra, D.A., Front Oncol, 1/1/2012
• Age and Comorbid Illness Are Associated with Late Rectal Toxicity Following Dose Escalated Radiation Therapy for Prostate Cancer  
  Hamstra, D.A, Stenmark, M.H., Ritter, T., Litzenberg, D., Jackson, W., Johnson, S., Albrecht-Unger, L., Donaghy, A., Phelps, L., Blas, K., Halverson, S., Marsh, R., Ol..., Int J Radiat Oncol Biol Phys, 1/1/2012
• Making the Appropriate Comparisons is Critical: In regard to Survival Among Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy or Radiati...  
  Stenmark, M.H. and Hamstra, D.A., J Urol, 1/1/2012
• Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer  
  Stenmark, M.H., Vineberg, K., Ten Haken, R.K., Hamstra, D.A., and Feng, M, Medical Dosim, 1/1/2012
• Randomized Phase II Trial of Urethral Sparing Intensity Modulated Radiation Therapy in Low-risk Prostate Cancer: Implications for Focal Therapy  
  Vainshtein, J., Abu-Isa, E., Olson, K.B., Ray, M.E., Sandler, H.M., Normolle, D., Litzenberg, D.W., Masi, K., Pan, C., Hamstra, D.A., Radiat Oncol, 1/1/2012
• The Role of The Maximum Involvement of Biopsy Core In Predicting Outcome For Patients Treated with Dose-Escalated Radiation Therapy For Prostate Cancer  
  Murgic, J., Stenmark, M.H., Halverson, S., Blas, K., Feng, F.Y., and Hamstra, D.A., Radiat Oncol, 1/1/2012
• Percent Cancer Volume in Biopsy Cores is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated with Dose-Escalated External Beam Radiotherapy  
  Vance, S.M., Stenmark, M.H., Blas, K., Halverson, S., Hamstra, D.A. and Feng, F.Y., Int J Radiat Oncol Biol Phys, 1/1/2012
• Perineural Invasion Predicts Increased Recurrence, Metastasis, and Death from Prostate Cancer following Treatment with Dose-Escalated Radiation Therapy  
  Feng FY, Qian Y, Stenmark MH, Halverson S, Blas K, Vance S, Sandler HM, Hamstra DA, Int J Radiat Oncol Biol Phys, 1/1/2011
• Adjuvant radiotherapy after radical prostatectomy: evidence and analysis  
  Raldow A, Hamstra DA, Kim SN, Yu JB, Cancer Treatment Reviews, 1/1/2011
• Prospective analysis of parametric MRI biomarkers: Identification of early and distinct glioma response patterns not predicted by standard radiographic assessment  
  Galban CJ, Chenevert TL, Meyer CR, Tsien CI, Lawrence TS, Hamstra DA, Junck L, Sundgren P, Johnson TD, Galban S, Sebolt-Leopold J, Rehemtulla A, Ross BD, Clin Cancer Res, 1/1/2011
• Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated with Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk D...  
  Stenmark MH, Blas K, Halverson S, Sandler HM, Feng FY, Hamstra DA, Int J Radiat Oncol Biol Phys, 1/1/2011
• Gleason Pattern 5 is the Greatest Risk Factor for Clinical Failure and Death from Prostate Cancer after Dose-Escalated Radiation Therapy and Hormonal Ablation  
  Sabolch A, Feng FY, Daignault-Newton S, Halverson S, Blas K, Phelps L, Olson KB, Sandler HM, Hamstra DA, Int J Radiat Oncol Biol Phys, 1/1/2011
• Older Age Predicts Decreased Metastasis and Prostate Cancer-Specific Death for Men Treated with Radiation Therapy: Meta-Analysis of Radiation Therapy Oncology Group Tr...  
  Hamstra DA, Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, Roach M, Lawton C, Lee RJ, Sandler H, Int J Radiat Oncol Biol Phys, 1/1/2011
• Outcomes of Multidisciplinary Management in Pediatric Low-Grade Gliomas  
  Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA, Int J Radiat Oncol Biol Phys, 1/1/2011
• Join now to see all

Books/Book Chapters

• Treatment Planning in Radiation Oncology 
  Chapter: Genitourinary Malignancies: Prostate, Bladder, and Testis. 
  Hamstra, D.A, & Ray, M.E.Editors: F.M. Khan, B.J. Gerbi, and K.E. Dusenbery.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,2011

Abstracts/Posters

• The Interval to Biochemical Failure is Prognsotic for Metastasis, Prostate Cancer Specific Death, and Overall Mortality Following Salvage Radiotherapy for Prostate Can...
  Johnson, S., Jackson, W.C., Foster, C., Li, D., Palapattu, G.S., Sandler, H.M., Feng, F.Y., Hamstra, D.A., 55th Annual Meeting of ASTRO, Atlanta, GA, 9/1/2013
• The Impact of Anticoagulant Use on Clinical Outcomes In Men Treated with Definitive and Salvage Radiotherapy.
  Johnson, S., Jackson, W.C., Foster, B., Song, Y., Palapattu, G.S., Sandler, H.M., Hamstra, D.A., and Feng, F.Y., 55th Annual Meeting of ASTRO, Atlanta, GA, 9/1/2013
• Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy.
  Jackson, W,C, Johnson, S.B., Foster, C., Li, D., Sandler, H.M., Palapattu, G.S., Hamstra, D.A., and Feng, F.Y., 55th Annual Meeting of ASTRO, Atlanta, GA, 9/1/2013
• Dose to the Inferior Rectum Has the Strongest Association with Patient-Reported Bowel Quality of Life (QOL) after External Beam Radiation Therapy (EBRT) for Prostate C...
  Stenmark, M.H., Johnson, S., Conlon, A.S., Daignault, S., Marsh, R., Ritter, T., Litzenberg, D., Sandler, H.M., Sanda, M.G., and Hamstra, D.A., 55th Annual Meeting of ASTRO, Atlanta, GA, 9/1/2013
• Comparative Effectiveness Study of Proton Therapy versus IMRT for Definitive Prostate Cancer Treatment Based On Patient-Reported Outcomes.
  Hoppe, B.S., Michalski, J.M., Mendenhall, N.P., Morris, C.G., Henderson, R.H., Nichols, R.C., Regan, M.M., Sandler, H.M., Sanda, M.G., and Hamstra, D.A., 55th Annual Meeting of ASTRO, Atlanta, GA, 9/1/2013
• PSA Doubling time <=6 months as the optimal cutoff for prediction of clinically relevant outcomes for men receiving salvage radiation therapy post radical prostatec...
  Jackson, W.C., Johnson, S.B., Foster, B., Foster, C., Song, Y., Li, D., Sandler, H.M., Palatattu, G.S., Hamstra, D.A., and Feng, F.Y., Genitourinary Cancers Symposium, Orlando, FL, 2/1/2013
• Prediction of patient-report bowel quality of life (QOL) after dose-escalated radiation therapy (RT) for prostate cancer by rectal dosimetry.
  Stenmark, M.H., Conlon, A.S.C., Daignault, S., Bassetti, M.F., Vance, S., Marsh, R., Litzenberg, D., Ritter, T., Feng, F.Y., Sandler, H.M., Sanda, M.G., and Hamstra, D.A., Genitourinary Cancers Symposium, Orlando, FL, 2/1/2013
• Maximum Tumor Diameter as a Predictor of Outcome Following Salvage Radiation for Prostate Cancer.
  Johnson, S.B., Jackson, W.C., Song, Y., Foster, B., Li, D., Foster, C. Palapattu, G., Mehra, R., Kunju, P., Feng, F.Y., and Hamstra, D.A., Genitourinary Cancers Symposium, Orlando, FL, 2/1/2013
• Gleason Pattern 5 as a Pathologic Predictor of Recurrence, Development of Metastasis, and Prostate-Cancer Specific Death for Patients Receiving Salvage Radiation Thera...
  Jackson, W.C., Johnson, S.B., Foster, C., Li, D., Foster, B., Song, Y. Sandler, H.M., Palapattu, G., Kunju, P., Mehra, R., Hamstra, D.A., and Feng, F.Y., Genitourinary Cancers Symposium, Orlando, FL, 2/1/2013
• Presenting Longitudial Data: Does Type of Graphical Format Matter?
  Fagerlin, A., Zikmund-Fisher, B.J., Larkin, K., and Hamstra, D.A., 34th Annual Meeting of the Society for Medical Decision Making, Phoenix, AZ, 10/1/2012
• Rectal NTCP as Well As Both Age and Co-Morbid Illness Predict Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Localized Prostate Cancer.
  Albrecht-Unger, L., Donaghy, A., Feng, F.Y., and Hamstra, D.A., ACRO Annual Meeting, Fort Meyers, FL, 2/23/2012
• Rectal NTCP as Well As Both Age and Co-Morbid Illness Predict Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Localized Prostate Cancer.
  Hamstra, D.A., Stenmark, M., Donaghy, A., Albrecht-Unger, L., and Feng, F, 12th Annual Meeting of The Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT), Eilat, Israel, 1/12/2012
• ERG Gene Fusions as a Prognostic Tumor Biomarker in Prostate Cancer Patients Treated with Salvage Radiotherapy.
  Song, Y.1, Bhalla, R., Siddiqui, J., Chinnaiyan, A.M., Hamstra, D.A., Mehra, R., Kunju, L.P., and Feng, F.Y., 54th Annual Meeting of ASTRO, Boston, MA, 1/1/2012
• Gleason Pattern 5 Is Associated with an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902.
  Hamstra, DA, Hunt D, Grignon, D., Hanks, GE, Peters, C, Rosenthal, SA, Lock, MI, Zeitzer, K, Souhami, L, and Sandler, H, 54th Annual Meeting of ASTRO, Boston, MA, 1/1/2012
• The Addition of Low Dose Rate Brachytherapy and Androgen Deprivation Therapy Decreases Prostate Cancer Death Compared to Dose Escalated External Beam Radiation Therapy...
  Shilkrut, M., McLaughlin, W.P., Stenmark, M.H., Abu-Isa, E., Vance, S.M., Sandler, H.M., Evans, C., Feng, F.Y., Merrick, G, and Hamstra, D.A., 54th Annual Meeting of ASTRO, Boston, MA, 1/1/2012
• Surrogate End-Points for Prostate Cancer Specific Survival: Superiority of the Interval to Biochemical Failure: An Analysis of RTOG 9202 and 9413.
  Hamstra. D.A., Dignam, J.J, Porter, A., Hanks, G.E., Lawton, C., Roach, M. III, Sandler, H.M., 53nd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Utilizing Gleason Pattern 5 to Refine Risk Stratification for Prostate Cancer Patients Treated with Dose-Escalated Radiotherapy and Androgen Deprivation Therapy.
  Sabolch, A, Feng, F.Y., Daignault-Netwon, S., Halverson, S., Blas, K., Phelps, L., Olson, K.B., Sandler, H.M., and Hamstra, D.A., ASCO Multidisciplinary Genitourinary Cancers Symposia, Orlando, FL, 1/1/2011
• The percent of positive biopsy cores improves prediction of prostate cancer specific death in patients treated with dose-escalated radiotherapy.
  Qiang, Y., Feng, F.Y., Halverson, S., Blas, K., Sandler, H.M., and Hamstra, D.A., ASCO Multidisciplinary Genitourinary Cancers Symposia, Orlando, FL, 1/1/2011
• The interval to biochemical failure versus biochemical failure as predictors for cause specific- and overall survival following dose-escalated external beam radiation ...
  Kapadia, N., Feng, F.Y., Sandler, H.M., and Hamstra, D.A., ASCO Annual Meeting, Chicago, IL, 1/1/2011
• PARP Inhibition Reverses Radiation Resistance Conferred by ETS Fusions in Prostate Cancer.
  Feng, F.Y., Han, S., Brenner, C., Sabolch, A., Hamstra, D.A., Lawrence, T.S., and Chinnaiyan, A, ASCO Annual Meeting, Chicago, IL, 1/1/2011
• Weekly On-Treatment Assessment of Genito-Urinary Symptoms using a modification of the AUA Symptom Index Worksheet for Patients Receiving Radiation for Prostate Cancer.
  Howell, D.D., Schipper, M., and Hamstra, D.A., 53rd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Combination Therapy Improves Prostate Cancer Survival For Patients With Potentially Lethal Prostate Cancer: The Impact of Gleason Pattern 5
  Hamstra, D.A., Abu-Isa, E., Jawad, M.S., Feng, F.Y., Vance, S., Winfield, R., Narayana, V., Sandler, H.M., and McLaughlin, P.W., 53rd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Combination Low Dose Rate Brachytherapy and External Beam Radiation Treatment in Patients with Intermediate and High Risk Prostate Cancer
  Abu-Isa, E., Jawad, M.S., Dilts, C, Geraghty, G., Narayana, V., Hamstra, D.A., and McLaughlin, P.W, 53rd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Urethral Sparing Intensity Modulated Radiation Does Not Improve Urinary Quality of Life: Results of a Randomized Phase 2 Trial.
  Vainshtein, J., Abu-Isa, E., Olson, K., Ray, M.E., Sandler, H.M., Normolle, D., Pan, C.C., and Hamstra, D.A., 53nd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Prostate Cancer Radiation Enhancement Through mTOR Pathway Inhibition: The Role of Tumor and Vascular Compartments.
  Hamstra, D.A., Zhang, Y., Feng, F.Y., Bhojani, S.M., and Sharma, N, 53nd Annual Meeting of ASTRO, Miami, FL, 1/1/2011
• Join now to see all

Lectures

• Radiation Therapy 
• Patient Reported Quality of Life Following Radiation Therapy for Prostate Cancer. 
  Atlanta, GA - 9/1/2013
• RTOG 9910: A Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate-Risk Prostate Cancer. 
  Atlanta, GA - 9/1/2013
• Intra-treatment MRI During Radiation Therapy for CNS Malignancies: Insights Into Tumor Response and Normal Tissue Toxicity 
  Mayo Clinic, Scottsdale, AZ - 7/1/2013
• Hypofractionated and Stereotactic Body Radiation Therapy for Localized Prostate Cancer. 
  Cedars Sinai Medical Center, Los Angeles, CA - 7/1/2013
• Bladder Cancer: Bladder Preservation, Non-Invasive Cancers, Patterns of Failure: The Role of 
  Ann Arbor, MI - 5/1/2013
• Introduction to Radiation Oncology: Physics, Biology, and Clinical Considerations. 
  University of Michigan, Ann Arbor, MI - 4/1/2013
• Medulloblastoma: Radiation Management. 
  University of Michigan, Ann Arbor, MI - 4/1/2013
• Rhabdomyosarcoma: The role of radiation therapy. 
  Ann Arbor, MI - 4/1/2013
• Margin Reduction with Calypso for Prostate: Conventional Fractionation to SBRT. Invited Speaker 
  Carlsbad, CA - 2/20/2013
• Difficult Cases in High Risk Prostate Cancer. Panel Discussion Member 
  Orlando, FL - 2/14/2013
• Introduction to Radiation Oncology. Invited Speaker 
  Ann Arbor, MI - 12/1/2012
• Update on Radiation Therapy for Medulloblastoma. Invited Speaker 
  Georgetown University Medical Center, Washington, DC - 11/1/2012
• Difficult Cases in Pediatric Brain Tumors Embryonal CNS Tumors. Invited Speaker 
  Boston, MA - 10/1/2012
• Neuroblastoma: The Role of Radiation Therapy. 
  University of Michigan, Ann Arbor, MI - 9/1/2012
• Wilms Tumor: The Role of Radiation Therapy. 
  University of Michigan, Ann Arbor, MI - 9/1/2012
• RTOG 1115: Introduction and Overview. Invited Speaker 
  Philadelphia, PA - 6/15/2012
• Management of Medulloblastoma: Current Practice. 
  University of Michigan, Ann Arbor, MI - 5/1/2012
• Radiation Therapy For Local Progression of Hormone Refractory Prostate Cancer. 
  University of Michigan, Ann Arbor, MI - 5/1/2012
• Adjuvant and Salvage Radiation Therapy following Radical Prostatectomy. 
  University of Michigan, Ann Arbor, MI - 4/1/2012
• Introduction to Pediatric Radiation Oncology. 
  University of Michigan, Ann Arbor, MI - 4/1/2012
• Pediatric Radiation Oncology: Current Issues and Practice Management. 
  Georgetown University Medical Center, Washington, DC - 3/1/2012
• Radiation Therapy in Bladder Cancer. 
  University of Michigan, Ann Arbor, MI - 3/1/2012
• Principles of Radiation Oncology and Cancer Biology. 
  University of Michigan, Ann Arbor, MI - 3/1/2012
• Radiation Therapy for Pediatric Ependymoma. 
  University of Michigan, Ann Arbor, MI - 3/1/2012
• Join now to see all